Myelodysplastic syndrome

Disease2 papers

Humans1

Trial sponsors

Geron Corporation
Company1 trialPhase 2/3289 people
Chimeric Therapies
Company1 trialPhase 2/3
Takeda
Company1 trialPhase 242 people
Amgen
Company1 trialPhase 124 people
Eleos, Inc.
Company1 trialPhase 19 people
University of Maryland Baltimore
1 trialPhase 445 people
Fred Hutchinson Cancer Center
11 trialsPhase 3670 people
European Organisation for Research and Treatment of Cancer - EORTC
2 trialsPhase 3207 people

Latest

3

Disease Models & MechanismsAnimalsYesterday

Loss of transcriptional factor Zbtb33 fails to induce clonal hematopoiesis in mice but plays a role in tumor growth

Blood and immune system

Blood AdvancesHumans24 Sep

Grip strength is associated with overall survival in myelodysplastic syndrome

EJHaemResearch24 Sep

Reversible Eltrombopag-Associated Bone Marrow Fibrosis With Hematologic Recovery After Drug Withdrawal in ASXL1-Mutated Hypoplastic Myelodysplastic Syndrome: A Case Report